1-8 |
Acyclovir |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Acyclovir [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
1-8 |
|
|
|
|
Both |
|
|
|
0 |
Acyclovir Susc Islt |
|
|
|
|
|
Aciclovir; Acifur; ACV; Acycloguanosine; ANTIBIOTIC SUSCEPTIBILITIES; AST; Avirax; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zovirax |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10-9 |
Amdinocillin |
Titr |
Isolate+Ser |
Pt |
SemiQn |
SBT |
|
ACTIVE |
Amdinocillin [Susceptibility] by Serum bactericidal titer |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
ABXBACT |
|
10-9 |
|
SBT |
|
|
Observation |
|
|
|
0 |
Amdinocillin Titr SBT |
|
|
|
|
|
Amdinocillin pivoxil; ANTIBIOTIC SUSCEPTIBILITIES; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mecillinam; Pivmecilliam; Point in time; Random; Selexid; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
100-8 |
Cefoperazone |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
100-8 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Cefoperazone Islt MIC |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefobid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1000-9 |
DBG Ab |
PrThr |
Ser/Plas^BPU |
Pt |
Ord |
|
|
ACTIVE |
DBG Ab [Presence] in Serum or Plasma from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1000-9 |
|
|
|
|
Observation |
|
|
|
0 |
DBG Ab SerPl BPU Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Donna Bennett-Goodspeed; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
10000-8 |
R wave duration.lead AVR |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave duration in lead AVR |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10000-8 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave dur L-AVR |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-AVR; R wave dur L-AVR; Random; Right |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
100000-9 |
Health informatics pioneer and the father of LOINC |
Hx |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Health informatics pioneer and the father of LOINC |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
100000-9 |
|
|
|
|
Observation |
|
|
|
0 |
Health Info Pioneer+Father of LOINC |
|
|
|
N |
|
Clem McDonald; Dr. Clement J. McDonald Jr.; H+P; H+P.HX; Health Info Pioneer+Father of LOINC; History; Honorary; Logical Observation Identifiers Names and Codes; Narrative; P prime; Point in time; Random; Report |
2.74 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100001-7 |
Health informatics pioneer and cofounder of LOINC |
Hx |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Health informatics pioneer and cofounder of LOINC |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
100001-7 |
|
|
|
|
Observation |
|
|
|
0 |
Health Info Pioneer+Cofound LOINC |
|
|
|
N |
|
Dr. Stanley M. Huff; H+P; H+P.HX; Health Info Pioneer+Cofound LOINC; History; Honorary; Logical Observation Identifiers Names and Codes; Narrative; P prime; Point in time; Random; Report; Stan Huff |
2.74 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100002-5 |
Specimen care is maintained |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Specimen care is maintained |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100002-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100003-3 |
Team communication is maintained throughout care |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Team communication is maintained throughout care |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100003-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100004-1 |
Demonstrates knowledge of the expected psychosocial responses to the procedure |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Demonstrates knowledge of the expected psychosocial responses to the procedure |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100004-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100005-8 |
Demonstrates knowledge of nutritional management related to the procedure |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Demonstrates knowledge of nutritional management related to the procedure |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100005-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100006-6 |
Demonstrates knowledge of medication management |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Demonstrates knowledge of medication management |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100006-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100007-4 |
Demonstrates knowledge of pain management |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Demonstrates knowledge of pain management |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100007-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100008-2 |
Demonstrates knowledge of wound management |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Demonstrates knowledge of wound management |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100008-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100009-0 |
Demonstrates knowledge of the procedure and expected results |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Demonstrates knowledge of the procedure and expected results |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100009-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10001-6 |
R wave duration.lead I |
Time |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave duration in lead I |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
EKG.MEAS |
|
10001-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave dur L-I |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Durat; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave dur L-I; R wave dur L-I; Random; Right |
2.48 |
1.0i |
|
|
|
|
|
|
|
s |
|
|
|
0 |
100010-8 |
No injury related to procedure equipment, medical supplies, or instrumentation |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to procedure equipment, medical supplies, or instrumentation |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100010-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100011-6 |
No injury related to an electrical source |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to an electrical source |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100011-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100012-4 |
Participates in decisions affecting the patient's plan of care |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Participates in decisions affecting the patient's plan of care |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100012-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100013-2 |
Participates in the discharge process |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Participates in the discharge process |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100013-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100014-0 |
Psychosocial health is maintained at or improved from baseline |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Psychosocial health is maintained at or improved from baseline |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100014-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100015-7 |
No injury related to positioning due to care or procedure |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to positioning due to care or procedure |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100015-7 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100016-5 |
No injury related to a laser source |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to a laser source |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
100016-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
100017-3 |
Perioperative nursing data set outcomes panel |
- |
^Patient |
Pt |
- |
PNDS |
|
ACTIVE |
Perioperative nursing data set outcomes panel [PNDS] |
|
ADD |
DefinitionDescription |
|
|
|
|
�©AORN Syntegrity, Inc. Used with permission.Commercial or facility use requires a license from AORN Syntegrity or an authorized reseller. |
|
|
|
|
PANEL.SURVEY.PNDS |
|
100017-3 |
|
PNDS |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Pan; Panl; PNDS outcomes panel; Pnl; Point in time; Random; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
Panel |
|
|
�©AORN Syntegrity, Inc. Used with permission.Commercial or facility use requires a license from AORN Syntegrity or an authorized reseller. |
|
|
|
|
|
|
0 |
100018-1 |
Note |
Find |
{Setting} |
Pt |
Doc |
Hospice care |
|
ACTIVE |
Hospice care Note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100018-1 |
|
Hospice care |
|
|
Both |
|
|
|
0 |
Hospice care Note |
|
|
|
N |
|
Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |